BrainMetScore

Survival benefits of adding palliative WBRT in NSCLC with brain metastases unsuitable for resection or radiosurgery

Gender

Male
Female

Performance status

< 70%
≥ 70%

Extracranial disease

Controlled lung and no extra-cranial metastasis
Controlled lung disease and extra-cranial metastasis
Uncontrolled lung disease or extra-cranial metastasis
Newly diagnosis lung cancer with any extra-cranial metastasis

Previous systemic treatment

Neurosymptom

Mild
Moderate
Severe

Further systemic treatment

Predicted outcomes

Predicted median survival time (weeks)

WBRT No WBRT

Predicted Survival Probability at


	1 Month	2 Month	3 Month
WBRT
No WBRT

This calculator was developed at Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand and has been externally validated at Sawanpracharak hospital, Nakhonsawan, Thailand.